Erin F. Gillespie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Erin F. Gillespie has a total of 354 co-authors. Here are the top co-authors by number of shared publications:
Diana Lin
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
9 shared publicationsJames D. Murphy
University of California San Diego
8 shared publicationsOren Cahlon
Departments of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
8 shared publicationsKaitlyn Lapen
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
7 shared publicationsJonathan T. Yang
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
6 shared publications- Raymond S. Douglas
Department of Orbital and Ophthalmic Plastic Surgery, Thrive Health, Beverly Hills, California
6 shared publications
Latest Publications
- 13 June 2026
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 38, 151045
Clinical Trials of Integrative Oncology Interventions for Radiation Therapy: Emerging Evidence and Opportunities
- 13 June 2026
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 38, 151045
Clinical Trials of Integrative Oncology Interventions for Radiation Therapy: Emerging Evidence and Opportunities
- Open Access
- 16 January 2026
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 12 (1) , e80075
Benefits and Challenges of a Digital Exercise and Mind-Body Program During Active Cancer Treatment: Qualitative Study of Patients’ Perceptions
Background: Individuals undergoing cancer treatment often face a high symptom burden that impairs quality of life. Exercise and mind-body therapies have been shown to reduce symptoms but are underused. We developed a digital exercise and mind-body therapy program that effectively reduces symptoms while overcoming in-person delivery barriers. Understanding patient experiences can inform treatment mechanisms and guide digital health interventions in cancer care. Objective: This study aimed to explore patient experiences with Integrative Medicine at Home (IM@Home), a 12-week live digital program delivering exercise and mind-body therapies tailored to the needs of individuals undergoing cancer treatment. Methods: This qualitative study was embedded in a randomized clinical basket trial (NCT05053230) evaluating the effects of IM@Home versus enhanced usual care on symptoms and acute health care utilization in adults with solid tumors undergoing active treatment and experiencing moderate or greater fatigue. Using maximum variation sampling, 20 participants were selected for semistructured interviews. Interviews explored participants’ experiences with the program, its impact on outcomes, unmet needs, and suggestions for improvement. Transcripts were analyzed using a combined inductive and deductive thematic analysis. Results: Twenty participants (mean age 63, SD 9.6 years; 18/20, 90% female) were interviewed. Five major themes emerged: (1) IM@Home alleviated symptom burden and supported symptom self-management; (2) IM@Home facilitated social support and information exchange; (3) IM@Home offered a flexible, tailored program in a group setting; (4) IM@Home facilitated accessible, cost-effective support; and (5) recommendations for program enhancement. IM@Home was perceived as an accessible, flexible, and supportive program that promoted physical and emotional well-being during treatment. Conclusions: IM@Home demonstrates a promising model for delivering integrative supportive care during cancer treatment. Findings highlight patient-valued features such as real-time guidance, tailored content, and community support. These insights can inform future implementation, integration into clinical care, and efforts to enhance digital mind-body interventions in oncology. Trial Registration: ClinicalTrials.gov NCT05053230; https://www.clinicaltrials.gov/study/NCT05053230 International Registered Report Identifier (IRRID): RR2-10.1038/s41746-024-01387-z
- 16 January 2026
- Published by JMIR Publications Inc. in JMIR Cancer
- Vol. 12 (1) , e80075
Open AccessBenefits and Challenges of a Digital Exercise and Mind-Body Program During Active Cancer Treatment: Qualitative Study of Patients’ Perceptions
Background: Individuals undergoing cancer treatment often face a high symptom burden that impairs quality of life. Exercise and mind-body therapies have been shown to reduce symptoms but are underused. We developed a digital exercise and mind-body therapy program that effectively reduces symptoms while overcoming in-person delivery barriers. Understanding patient experiences can inform treatment mechanisms and guide digital health interventions in cancer care. Objective: This study aimed to explore patient experiences with Integrative Medicine at Home (IM@Home), a 12-week live digital program delivering exercise and mind-body therapies tailored to the needs of individuals undergoing cancer treatment. Methods: This qualitative study was embedded in a randomized clinical basket trial (NCT05053230) evaluating the effects of IM@Home versus enhanced usual care on symptoms and acute health care utilization in adults with solid tumors undergoing active treatment and experiencing moderate or greater fatigue. Using maximum variation sampling, 20 participants were selected for semistructured interviews. Interviews explored participants’ experiences with the program, its impact on outcomes, unmet needs, and suggestions for improvement. Transcripts were analyzed using a combined inductive and deductive thematic analysis. Results: Twenty participants (mean age 63, SD 9.6 years; 18/20, 90% female) were interviewed. Five major themes emerged: (1) IM@Home alleviated symptom burden and supported symptom self-management; (2) IM@Home facilitated social support and information exchange; (3) IM@Home offered a flexible, tailored program in a group setting; (4) IM@Home facilitated accessible, cost-effective support; and (5) recommendations for program enhancement. IM@Home was perceived as an accessible, flexible, and supportive program that promoted physical and emotional well-being during treatment. Conclusions: IM@Home demonstrates a promising model for delivering integrative supportive care during cancer treatment. Findings highlight patient-valued features such as real-time guidance, tailored content, and community support. These insights can inform future implementation, integration into clinical care, and efforts to enhance digital mind-body interventions in oncology. Trial Registration: ClinicalTrials.gov NCT05053230; https://www.clinicaltrials.gov/study/NCT05053230 International Registered Report Identifier (IRRID): RR2-10.1038/s41746-024-01387-z
- 19 November 2025
- Published by Elsevier in Practical Radiation Oncology
- Vol. 16 (3) , 234-242
Association of a Disease Site Specific Chart Rounds Format With Peer Review Feedback: A Prospective Study
- 19 November 2025
- Published by Elsevier in Practical Radiation Oncology
- Vol. 16 (3) , 234-242
Association of a Disease Site Specific Chart Rounds Format With Peer Review Feedback: A Prospective Study
- 5 November 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 124 (4) , 961-970
A Virtual Mind-Body Exercise Program During Breast Radiation: Results From a Randomized Controlled Basket Trial
- 5 November 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 124 (4) , 961-970
A Virtual Mind-Body Exercise Program During Breast Radiation: Results From a Randomized Controlled Basket Trial
- 18 July 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 211, 111048
Evaluating risk factors for skeletal-related events among bone metastases from solid tumors
- 18 July 2025
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 211, 111048
Evaluating risk factors for skeletal-related events among bone metastases from solid tumors
- Open Access
- 3 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Benefits and Challenges of a Digital Exercise and Mind-Body Program During Active Cancer Treatment: Qualitative Study of Patients’ Perceptions (Preprint)
BACKGROUND Individuals undergoing cancer treatment often face a high symptom burden that impairs quality of life. Exercise and mind-body therapies have been shown to reduce symptoms but are underused. We developed a digital exercise and mind-body therapy program that effectively reduces symptoms while overcoming in-person delivery barriers. Understanding patient experiences can inform treatment mechanisms and guide digital health interventions in cancer care. OBJECTIVE This study aimed to explore patient experiences with Integrative Medicine at Home (IM@Home), a 12-week live digital program delivering exercise and mind-body therapies tailored to the needs of individuals undergoing cancer treatment. METHODS This qualitative study was embedded in a randomized clinical basket trial (NCT05053230) evaluating the effects of IM@Home versus enhanced usual care on symptoms and acute health care utilization in adults with solid tumors undergoing active treatment and experiencing moderate or greater fatigue. Using maximum variation sampling, 20 participants were selected for semistructured interviews. Interviews explored participants’ experiences with the program, its impact on outcomes, unmet needs, and suggestions for improvement. Transcripts were analyzed using a combined inductive and deductive thematic analysis. RESULTS Twenty participants (mean age 63, SD 9.6 years; 18/20, 90% female) were interviewed. Five major themes emerged: (1) IM@Home alleviated symptom burden and supported symptom self-management; (2) IM@Home facilitated social support and information exchange; (3) IM@Home offered a flexible, tailored program in a group setting; (4) IM@Home facilitated accessible, cost-effective support; and (5) recommendations for program enhancement. IM@Home was perceived as an accessible, flexible, and supportive program that promoted physical and emotional well-being during treatment. CONCLUSIONS IM@Home demonstrates a promising model for delivering integrative supportive care during cancer treatment. Findings highlight patient-valued features such as real-time guidance, tailored content, and community support. These insights can inform future implementation, integration into clinical care, and efforts to enhance digital mind-body interventions in oncology. CLINICALTRIAL ClinicalTrials.gov NCT05053230; https://www.clinicaltrials.gov/study/NCT05053230 INTERNATIONAL REGISTERED REPORT RR2-10.1038/s41746-024-01387-z
- 3 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessBenefits and Challenges of a Digital Exercise and Mind-Body Program During Active Cancer Treatment: Qualitative Study of Patients’ Perceptions (Preprint)
BACKGROUND Individuals undergoing cancer treatment often face a high symptom burden that impairs quality of life. Exercise and mind-body therapies have been shown to reduce symptoms but are underused. We developed a digital exercise and mind-body therapy program that effectively reduces symptoms while overcoming in-person delivery barriers. Understanding patient experiences can inform treatment mechanisms and guide digital health interventions in cancer care. OBJECTIVE This study aimed to explore patient experiences with Integrative Medicine at Home (IM@Home), a 12-week live digital program delivering exercise and mind-body therapies tailored to the needs of individuals undergoing cancer treatment. METHODS This qualitative study was embedded in a randomized clinical basket trial (NCT05053230) evaluating the effects of IM@Home versus enhanced usual care on symptoms and acute health care utilization in adults with solid tumors undergoing active treatment and experiencing moderate or greater fatigue. Using maximum variation sampling, 20 participants were selected for semistructured interviews. Interviews explored participants’ experiences with the program, its impact on outcomes, unmet needs, and suggestions for improvement. Transcripts were analyzed using a combined inductive and deductive thematic analysis. RESULTS Twenty participants (mean age 63, SD 9.6 years; 18/20, 90% female) were interviewed. Five major themes emerged: (1) IM@Home alleviated symptom burden and supported symptom self-management; (2) IM@Home facilitated social support and information exchange; (3) IM@Home offered a flexible, tailored program in a group setting; (4) IM@Home facilitated accessible, cost-effective support; and (5) recommendations for program enhancement. IM@Home was perceived as an accessible, flexible, and supportive program that promoted physical and emotional well-being during treatment. CONCLUSIONS IM@Home demonstrates a promising model for delivering integrative supportive care during cancer treatment. Findings highlight patient-valued features such as real-time guidance, tailored content, and community support. These insights can inform future implementation, integration into clinical care, and efforts to enhance digital mind-body interventions in oncology. CLINICALTRIAL ClinicalTrials.gov NCT05053230; https://www.clinicaltrials.gov/study/NCT05053230 INTERNATIONAL REGISTERED REPORT RR2-10.1038/s41746-024-01387-z
- 1 February 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 21 (2) , 252-260
Palliative Care as a Component of High-Value and Cost-Saving Care During Hospitalization for Metastatic Cancer
PURPOSE: Randomized controlled trials have demonstrated that palliative care (PC) can improve quality of life and survival for outpatients with advanced cancer, but there are limited population-based data on the value of inpatient PC. We assessed PC as a component of high-value care among a nationally representative sample of inpatients with metastatic cancer and identified hospitalization characteristics significantly associated with high costs. METHODS: Hospitalizations of patients 18 years and older with a primary diagnosis of metastatic cancer from the National Inpatient Sample from 2010 to 2019 were analyzed. We used multivariable mixed-effects logistic regression to assess medical services, patient demographics, and hospital characteristics associated with higher charges billed to insurance and hospital costs. Generalized linear mixed-effects models were used to determine cost savings associated with provision of PC. RESULTS: Among 397,691 hospitalizations from 2010 to 2019, the median charge per admission increased by 24.9%, from $44,904 in US dollars (USD) to $56,098 USD, whereas the median hospital cost remained stable at $14,300 USD. Receipt of inpatient PC was associated with significantly lower charges (odds ratio [OR], 0.62 [95% CI, 0.61 to 0.64]; P < .001) and costs (OR, 0.59 [95% CI, 0.58 to 0.61]; P < .001). Factors associated with high charges were receipt of invasive medical ventilation ( P < .001) or systemic therapy ( P < .001), Hispanic patients ( P < .001), young age (18-49 years, P < .001), and for-profit hospitals ( P < .001). PC provision was associated with a $1,310 USD (–13.6%, P < .001) reduction in costs per hospitalization compared with no PC, independent of the receipt of invasive care and age. CONCLUSION: Inpatient PC is associated with reduced hospital costs for patients with metastatic cancer, irrespective of age and receipt of aggressive interventions. Integration of inpatient PC may de-escalate costs incurred through low-value inpatient interventions.
- 1 February 2025
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 21 (2) , 252-260
Palliative Care as a Component of High-Value and Cost-Saving Care During Hospitalization for Metastatic Cancer
PURPOSE: Randomized controlled trials have demonstrated that palliative care (PC) can improve quality of life and survival for outpatients with advanced cancer, but there are limited population-based data on the value of inpatient PC. We assessed PC as a component of high-value care among a nationally representative sample of inpatients with metastatic cancer and identified hospitalization characteristics significantly associated with high costs. METHODS: Hospitalizations of patients 18 years and older with a primary diagnosis of metastatic cancer from the National Inpatient Sample from 2010 to 2019 were analyzed. We used multivariable mixed-effects logistic regression to assess medical services, patient demographics, and hospital characteristics associated with higher charges billed to insurance and hospital costs. Generalized linear mixed-effects models were used to determine cost savings associated with provision of PC. RESULTS: Among 397,691 hospitalizations from 2010 to 2019, the median charge per admission increased by 24.9%, from $44,904 in US dollars (USD) to $56,098 USD, whereas the median hospital cost remained stable at $14,300 USD. Receipt of inpatient PC was associated with significantly lower charges (odds ratio [OR], 0.62 [95% CI, 0.61 to 0.64]; P < .001) and costs (OR, 0.59 [95% CI, 0.58 to 0.61]; P < .001). Factors associated with high charges were receipt of invasive medical ventilation ( P < .001) or systemic therapy ( P < .001), Hispanic patients ( P < .001), young age (18-49 years, P < .001), and for-profit hospitals ( P < .001). PC provision was associated with a $1,310 USD (–13.6%, P < .001) reduction in costs per hospitalization compared with no PC, independent of the receipt of invasive care and age. CONCLUSION: Inpatient PC is associated with reduced hospital costs for patients with metastatic cancer, irrespective of age and receipt of aggressive interventions. Integration of inpatient PC may de-escalate costs incurred through low-value inpatient interventions.
- 7 December 2024
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 121 (5) , 1102-1114
Dissemination and Implementation—A Primer for Accelerating “Time to Translation” in Radiation Oncology
- 7 December 2024
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 121 (5) , 1102-1114
Dissemination and Implementation—A Primer for Accelerating “Time to Translation” in Radiation Oncology